We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $4.11B
1-Year Est. Return 26.03%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+26.03%
3 Year Est. Return
+55.81%
5 Year Est. Return
+76.4%
10 Year Est. Return
+190.66%
AUM
$6.14B
AUM Growth
+$115M
Cap. Flow
-$618M
Cap. Flow %
-10.06%
Top 10 Hldgs %
13.68%
Holding
2,079
New
645
Increased
227
Reduced
394
Closed
739

Sector Composition

Rank Sector Weight
1 Miscellaneous 42.5%
2 Consumer Staples 9.3%
3 Healthcare 9.11%
4 Utilities 6.47%
5 Technology 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTO
1226
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$152K ﹤0.01%
10,950
-6,056
-36% -$92.3K
F icon
1227
CALL
Ford
F
$53.2B
$150K ﹤0.01%
11,900
-4,200
-26% -$55.4K
KRNY icon
1228
Kearny Financial
KRNY
$610M
$150K ﹤0.01%
+11,907
New +$153K
NWSA icon
1229
News Corp Class A
NWSA
$16.2B
$146K ﹤0.01%
+12,800
New +$154K
MITK icon
1230
Mitek Systems
MITK
$799M
$142K ﹤0.01%
20,038
-38,968
-66% -$291K
ETSY icon
1231
Etsy
ETSY
$6.74B
$140K ﹤0.01%
+14,645
New +$131K
NERV icon
1232
Minerva Neurosciences
NERV
$166M
$138K ﹤0.01%
+1,686
New +$107K
BNED icon
1233
Barnes & Noble Education
BNED
$363M
$135K ﹤0.01%
+133
New +$126K
SBS icon
1234
Sabesp
SBS
$18.6B
$132K ﹤0.01%
+75,801
New +$111K
LSCC icon
1235
Lattice Semiconductor
LSCC
$15.1B
$130K ﹤0.01%
+24,294
New +$135K
ARDX icon
1236
Ardelyx
ARDX
$875M
$129K ﹤0.01%
+14,730
New +$120K
OVV icon
1237
PUT
Ovintiv
OVV
$17.4B
$127K ﹤0.01%
3,260
-7,220
-69% -$264K
ARRY
1238
DELISTED
Array Biopharma Inc
ARRY
$125K ﹤0.01%
34,938
+15,257
+78% +$49.7K
DMTX
1239
DELISTED
Dimension Therapeutics, Inc
DMTX
$123K ﹤0.01%
+20,573
New +$157K
PACB icon
1240
Pacific Biosciences
PACB
$417M
$122K ﹤0.01%
+17,408
New +$159K
PRMW
1241
DELISTED
Primo Water Corporation
PRMW
$118K ﹤0.01%
+10,061
New +$112K
DCOY
1242
Decoy Therapeutics
DCOY
$1.89M
0
INO icon
1243
Inovio Pharmaceuticals
INO
$119M
$113K ﹤0.01%
+1,020
New +$124K
CMRX
1244
DELISTED
Chimerix, Inc.
CMRX
$112K ﹤0.01%
28,656
-12,115
-30% -$59.9K
OCUL icon
1245
Ocular Therapeutix
OCUL
$2.17B
$111K ﹤0.01%
+22,354
New +$221K
CZR
1246
DELISTED
Caesars Entertainment Corporation
CZR
$111K ﹤0.01%
14,364
-103,226
-88% -$766K
CTLP
1247
DELISTED
Cantaloupe
CTLP
$108K ﹤0.01%
+25,382
New +$109K
OSIR
1248
PUT
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$106K ﹤0.01%
+20,900
New +$113K
TNK icon
1249
Teekay Tankers
TNK
$3.49B
$105K ﹤0.01%
4,402
-13,892
-76% -$397K
GERN icon
1250
Geron
GERN
$829M
$97K ﹤0.01%
+36,150
New +$105K

Similar funds

Highbridge Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Highbridge Capital Management held 2,079 positions worth $6.14B, up 1.9% from $6.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Highbridge Capital Management withdrew a net $618M in Q2 2016, closing 739 positions and reducing 394 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $55.2M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, Highbridge Capital Management opened a new position in Target worth $47.8M.

  • Highbridge Capital Management's largest Q2 2016 buy was Target: 683,916 shares worth $47.8M.
  • Highbridge Capital Management added most to Coca-Cola Europacific Partners in Q2 2016, an estimated $84.8M increase.
  • Highbridge Capital Management's biggest Q2 2016 reduction was Southwestern Energy Company, cutting an estimated $43.9M.
  • Highbridge Capital Management fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $55.2M.
  • Highbridge Capital Management's ten largest holdings make up 14% of its $6.14B portfolio in Q2 2016.
  • Highbridge Capital Management opened 645 new positions and closed 739 in Q2 2016.
  • Highbridge Capital Management's portfolio value rose 1.9% quarter-over-quarter to $6.14B.

Based on Highbridge Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.